The Efficacy of Pain Management With Self-reporting Pain Monitoring System in Cancer Patient

Not Applicable

• Conditions: Pain
• Interventions: Device: using device for scoring pain scale, named "ANAPA®"

• Registration Number: NCT03117075
• Lead Sponsor: DERSHENG SUN

Brief Summary

To compare the pain scales between clinician evaluated and reported with wearable device by patients.

Detailed Description

To compare the pain scales between clinician evaluated and reported with wearable device by patients with cancer of advanced stage.

Study Timeline

• Study First Submitted: 2016-01-19
• Status Verified: 2017-04
• Study First Submitted QC: 2017-04-12
• Last Update Submitted: 2017-04-12
• Study First Posted: 2017-04-17
• Last Update Posted: 2017-04-17
• Study Start: 2017-05-15
• Primary Completion: 2017-11-14
• Study Completion: 2018-04-14

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 68

Inclusion Criteria

• over 20 year old
• cancer pain with visual analog scale or numeric rating scale score >/- 4
• opioids candidates
• with informed consent form

Exclusion Criteria

• life expectancy within 3 months

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Experimental	using device for scoring pain scale, named "ANAPA®"	using device for scoring pain scale, named "ANAPA®"

Primary Outcome Measures

Name	Time	Method
Actual difference of pain scales	1 week after using wearable pain scale device - baseline and 1 week.	comparing the pain scale assessed by wearable device and that assessed by physician when out patient clinic.

Trial Locations

Locations (2)

Daejeon St. Mary's Hospital, the Catholic University of Korea; 🇰🇷 Daejeon, Korea, Republic of

Seoul St. Mary's Hospital, the Catholic University of Korea; 🇰🇷 Seoul, Korea, Republic of